Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs

Otology and Neurotology

Volumn 34, Issue 1, 2013, Pages 41-47

  Du, Xiaoping ^a   Chen, Kejian ^a   Kuriyavar, Satish ^a   Kopke, Richard D ^a   Grady, Brian P ^b   Bourne, David H ^c   Li, Wei ^a   Dormer, Kenneth J ^d  

^a HOUGH EAR INSTITUTE   (United States)

^b University of Oklahoma   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Dexamethasone acetate; Magnetic targeting; Poly(lactide co glycolide); Round windowmembrane; Sensorineural hearing loss

Indexed keywords

DEXAMETHASONE; MAGNETITE NANOPARTICLE;

ANIMAL; ARTICLE; COCHLEA FENESTRA; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; GUINEA PIG; MALE; METABOLISM;

ANIMALS; DEXAMETHASONE; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; FEMALE; GUINEA PIGS; MAGNETITE NANOPARTICLES; MALE; ROUND WINDOW, EAR;

EID: 84871964443     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318277a40e     Document Type: Article

References (37)

1. Nakagawa T, Ito J. Drug delivery systems for the treatment of sensorineural hearing loss. Acta Otolaryngol 2007;127:30-5.
2. Swan EEL, Mescher MJ, Sewell WF, Tao SL, Borenstein JT. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008;60:1583-99.
3. McCall AA, Swan EEL, Borenstein JT, Sewell WF, Kujawa SG, McKenna MJ. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear 2010;31:156-65.
4. Borden RC, Saunders JE, Berryhill WE, Krempl GA, Thompson DM, Queimado L. Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane. Audiol Neu-rotol 2011;16:1-11.
5. Wang Y, Gao X, Kuriyavar S, et al. Incorporation, release and effectiveness of Dexamethasone in poly(lactic-co-glycolic acid) nanoparticles for inner ear drug delivery. J Nanotechnol Eng Med 2011; doi: 10, 1115/1.4002928.
6. Chandrasekhar SS. Intratympanic dexamethasone for sudden sen-sorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 2001;22:18-23.
7. Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005;44:61-98.
8. Liu HJ, Dong MM, Chi FL. Dexamethasone pharmacokinetics in guinea pig inner ear perilymph. ORL J Otorhinolaryngol Relat Spec 2006;68:93-8.
9. Piu F, Wang X, Fernandez R, et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurol 2011;32:171-9.
10. Kopke RD, Wassel RA, Mondalek F, et al. Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant. Otol Neurotol 2006;11:123-33.
11. Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydro-phobie drugs from PLGA/PLA nanoparticles. J Pharmaceutical Sci 2004;97:1804-14.
12. Gao X, Wang Y, Chen K, Grady B, Dormer K, Kopke R. Magnetic assisted transport of PLGA nanoparticles through a human round window membrane model. J Nanotechnol Eng Med 2010; doi: 10.1115/1.4002043.
13. Barnes AL, Wassel RA, Mondalek F, Chen K, Kopke RD, Dormer KJ. Magnetic characterization of superparamagnetic nanoparticles pulled through model membranes. Biomagn Res Tech 2007; doi10.1186/1477-044x-5-1.
14. Komaee A, Lee R, Nacev A, et al. Putting therapeutic nanoparticles where they need to go by magnetic systems design and control. In: TK Thanh, ed. Magnetic Nanoparticles: From Fabrication to Biomedical and Clinical Applications. Boca Raton, FL: CRC Press/Taylor & Francis, 2011.
15. Juhn SK, Hamaguchi Y, Goycoolea M. Review of round window membrane permeability. Acta Otolaryngol (Stock) 1988;457:43-8.
16. Borkholder DA. State-of-the-art mechanisms of intracochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg 2008;16:472-7.
17. Richardson RT, Wise AK, Andrew JK, O'Leary SJ. Novel drug delivery systems for inner ear protection and regeneration after hearing loss. Exp Opin Drug Del 2008;5:1059-76.
18. Zhang Y, Zhang W, Lobler M, et al. Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int J Pharmaceutics 2011;404:211-9.
19. Sun JJ, Liu Y, Kong WJ, Jiang P, Jiang W. In vitro permeability of round window membrane to transforming dexamethasone with delivery vehiclesVa dosage estimation. Chin Med J 2007;120:2284-9.
20. Sakamoto T, Nakagawa T, Horie RT, et al. Inner ear drug delivery system from the clinical point of view. Acta Otolaryngol 2010;130:101-104.
21. Plontke SK, Lowenheim H, Mertens J, et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009;119:359-69.
22. Sewell WF, Borenstein JT, Chen Z, et al. Development of a microfluidics-based intracochlear drug delivery device. Audiol Neurotol 2009;14:411-22.
23. Hornyak, GL: Nanotechnology in otolaryngology. Otolaryngol Clin North Am 2005;38:273-93.
24. Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech 1997;36:201-11.
25. Salt AN, Ma Y. Quantification of solute entry into cochlear peri-lymph through the round window membrane. Hear Res 2001;154:88-97.
26. Bala I, Hariharan S, Ravi Kumar MNV. PLGA nanoparticles in drug delivery: the state of the art. Critical Rev Therap Drug Carrier Syst 2004;21:387-422.
27. Fratoddi I, Venditti I, Cametti C, et al. Functional polymeric nanoparticles for dexamethasone loading and release. Colloids Surf B Biointerfaces 2012;93:59-66.
28. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives. J Control Rel 2008;125:193-209.
29. Gu F, Shang L, Teply B, et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copoly-mers. PNAS 2008;105:2586-91.
30. Csaba NS, Sanchez A, Alonso MJ. Preparation of poly(lactic acid) (PLA) and poly(ethylene oxide (PEO) as carriers for gene delivery. Cold Spring Harb Protoc 2010;doi: 10.1101/bdb.prot5468.
31. Reddy MK, Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J 2009;23:1384-95.
32. Horie RT, Sakamoto T, Nakagawa T, et al. Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid micro-particles. Laryngoscope 2009;120:377-83.
33. Wang X, Dellamary L, Fernandez R, Ye Q, LeBel C, Piu F. Principles of inner ear sustained release following intratympanic administration. Laryngoscope 2011;121:385-91.
34. Kim Dh, Martin DC. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for drug delivery. Biomaterials 2006;27:3031-7.
35. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1-17.
36. Chen G, Shang X, Yang F, Mu L. Disposition of nanoparticle-based delivery system via inner ear administration. Curr Drug Metab 2010;11:886-97.
37. Hahn H, Kammerer B, DiMauro A, Salt AN, Plontke SK. Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration. Hear Res 2006;212:236-44.